ACYL-COA SYNTHETASE 4 (ACSL4) INHIBITORY COMPOUND

A new compound of formula A for the treatment of aggressive and/or resistant tumors expressing acyl-CoA synthetase 4 (ACSL4) and/or depending on steroids action. More particularly, the compound of the present invention inhibits tumor growth in ACSL4-expressing breast and prostate cancers, inhibits s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SOLANO, Angela R, CASTILLO, Ana F, PRADA, Jessica G, ORLANDO, Ulises D, GOMEZ, Daniel E, MALOBERTI, Paula M, PODESTA, Ernesto J, RODRIGUEZ, Juan B, SZAJNMAN, Sergio H, LORENZANO MENNA, Pablo
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SOLANO, Angela R
CASTILLO, Ana F
PRADA, Jessica G
ORLANDO, Ulises D
GOMEZ, Daniel E
MALOBERTI, Paula M
PODESTA, Ernesto J
RODRIGUEZ, Juan B
SZAJNMAN, Sergio H
LORENZANO MENNA, Pablo
description A new compound of formula A for the treatment of aggressive and/or resistant tumors expressing acyl-CoA synthetase 4 (ACSL4) and/or depending on steroids action. More particularly, the compound of the present invention inhibits tumor growth in ACSL4-expressing breast and prostate cancers, inhibits steroid synthesis and sensitizes cells towards chemotherapeutic and hormone therapy agents. Pharmaceutical compositions comprising the ACSL4-inhibitory compound of the invention, pharmaceutical combinations thereof with other anticancer agents and use in therapy.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3927434A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3927434A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3927434A13</originalsourceid><addsrcrecordid>eNrjZDB0dI700XX2d1QIjvQL8XANcQx2VTBR0HB0DvYx0VTw9PPwdPIM8Q-KVHD29w3wD_Vz4WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxpZG5ibGJo6GxkQoAQDcgiXT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ACYL-COA SYNTHETASE 4 (ACSL4) INHIBITORY COMPOUND</title><source>esp@cenet</source><creator>SOLANO, Angela R ; CASTILLO, Ana F ; PRADA, Jessica G ; ORLANDO, Ulises D ; GOMEZ, Daniel E ; MALOBERTI, Paula M ; PODESTA, Ernesto J ; RODRIGUEZ, Juan B ; SZAJNMAN, Sergio H ; LORENZANO MENNA, Pablo</creator><creatorcontrib>SOLANO, Angela R ; CASTILLO, Ana F ; PRADA, Jessica G ; ORLANDO, Ulises D ; GOMEZ, Daniel E ; MALOBERTI, Paula M ; PODESTA, Ernesto J ; RODRIGUEZ, Juan B ; SZAJNMAN, Sergio H ; LORENZANO MENNA, Pablo</creatorcontrib><description>A new compound of formula A for the treatment of aggressive and/or resistant tumors expressing acyl-CoA synthetase 4 (ACSL4) and/or depending on steroids action. More particularly, the compound of the present invention inhibits tumor growth in ACSL4-expressing breast and prostate cancers, inhibits steroid synthesis and sensitizes cells towards chemotherapeutic and hormone therapy agents. Pharmaceutical compositions comprising the ACSL4-inhibitory compound of the invention, pharmaceutical combinations thereof with other anticancer agents and use in therapy.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211229&amp;DB=EPODOC&amp;CC=EP&amp;NR=3927434A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211229&amp;DB=EPODOC&amp;CC=EP&amp;NR=3927434A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SOLANO, Angela R</creatorcontrib><creatorcontrib>CASTILLO, Ana F</creatorcontrib><creatorcontrib>PRADA, Jessica G</creatorcontrib><creatorcontrib>ORLANDO, Ulises D</creatorcontrib><creatorcontrib>GOMEZ, Daniel E</creatorcontrib><creatorcontrib>MALOBERTI, Paula M</creatorcontrib><creatorcontrib>PODESTA, Ernesto J</creatorcontrib><creatorcontrib>RODRIGUEZ, Juan B</creatorcontrib><creatorcontrib>SZAJNMAN, Sergio H</creatorcontrib><creatorcontrib>LORENZANO MENNA, Pablo</creatorcontrib><title>ACYL-COA SYNTHETASE 4 (ACSL4) INHIBITORY COMPOUND</title><description>A new compound of formula A for the treatment of aggressive and/or resistant tumors expressing acyl-CoA synthetase 4 (ACSL4) and/or depending on steroids action. More particularly, the compound of the present invention inhibits tumor growth in ACSL4-expressing breast and prostate cancers, inhibits steroid synthesis and sensitizes cells towards chemotherapeutic and hormone therapy agents. Pharmaceutical compositions comprising the ACSL4-inhibitory compound of the invention, pharmaceutical combinations thereof with other anticancer agents and use in therapy.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB0dI700XX2d1QIjvQL8XANcQx2VTBR0HB0DvYx0VTw9PPwdPIM8Q-KVHD29w3wD_Vz4WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxpZG5ibGJo6GxkQoAQDcgiXT</recordid><startdate>20211229</startdate><enddate>20211229</enddate><creator>SOLANO, Angela R</creator><creator>CASTILLO, Ana F</creator><creator>PRADA, Jessica G</creator><creator>ORLANDO, Ulises D</creator><creator>GOMEZ, Daniel E</creator><creator>MALOBERTI, Paula M</creator><creator>PODESTA, Ernesto J</creator><creator>RODRIGUEZ, Juan B</creator><creator>SZAJNMAN, Sergio H</creator><creator>LORENZANO MENNA, Pablo</creator><scope>EVB</scope></search><sort><creationdate>20211229</creationdate><title>ACYL-COA SYNTHETASE 4 (ACSL4) INHIBITORY COMPOUND</title><author>SOLANO, Angela R ; CASTILLO, Ana F ; PRADA, Jessica G ; ORLANDO, Ulises D ; GOMEZ, Daniel E ; MALOBERTI, Paula M ; PODESTA, Ernesto J ; RODRIGUEZ, Juan B ; SZAJNMAN, Sergio H ; LORENZANO MENNA, Pablo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3927434A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SOLANO, Angela R</creatorcontrib><creatorcontrib>CASTILLO, Ana F</creatorcontrib><creatorcontrib>PRADA, Jessica G</creatorcontrib><creatorcontrib>ORLANDO, Ulises D</creatorcontrib><creatorcontrib>GOMEZ, Daniel E</creatorcontrib><creatorcontrib>MALOBERTI, Paula M</creatorcontrib><creatorcontrib>PODESTA, Ernesto J</creatorcontrib><creatorcontrib>RODRIGUEZ, Juan B</creatorcontrib><creatorcontrib>SZAJNMAN, Sergio H</creatorcontrib><creatorcontrib>LORENZANO MENNA, Pablo</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SOLANO, Angela R</au><au>CASTILLO, Ana F</au><au>PRADA, Jessica G</au><au>ORLANDO, Ulises D</au><au>GOMEZ, Daniel E</au><au>MALOBERTI, Paula M</au><au>PODESTA, Ernesto J</au><au>RODRIGUEZ, Juan B</au><au>SZAJNMAN, Sergio H</au><au>LORENZANO MENNA, Pablo</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ACYL-COA SYNTHETASE 4 (ACSL4) INHIBITORY COMPOUND</title><date>2021-12-29</date><risdate>2021</risdate><abstract>A new compound of formula A for the treatment of aggressive and/or resistant tumors expressing acyl-CoA synthetase 4 (ACSL4) and/or depending on steroids action. More particularly, the compound of the present invention inhibits tumor growth in ACSL4-expressing breast and prostate cancers, inhibits steroid synthesis and sensitizes cells towards chemotherapeutic and hormone therapy agents. Pharmaceutical compositions comprising the ACSL4-inhibitory compound of the invention, pharmaceutical combinations thereof with other anticancer agents and use in therapy.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3927434A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ACYL-COA SYNTHETASE 4 (ACSL4) INHIBITORY COMPOUND
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T08%3A15%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SOLANO,%20Angela%20R&rft.date=2021-12-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3927434A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true